Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | -2.79% | +8.93% | -65.92% |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
Business Summary
Number of employees: 176
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 43 | 100.0 % | 34 | 100.0 % | -21.41% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 43 | 100.0 % | 34 | 100.0 % | -21.41% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,813,327 | 7,042,899 ( 50.99 %) | 411,952 ( 2.982 %) | 50.99 % |
Company contact information
CASI Pharmaceuticals, Inc.
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road
100025, Beijing
+
http://www.casipharmaceuticals.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.92% | 31.69M | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- CASI Stock
- Company CASI Pharmaceuticals, Inc.